Integrated mobile health management system in patient with Decompensated liver disease for monitoring disease progression , Drug compliance , Rehabilitation and quality of life improvement through mobile application

The Integrated Mobile Health Management System (IMHMS) is a revolutionary solution

tailored for patients with Decompensated Liver Disease (DCLD). DCLD signifies an

advanced stage of liver disease characterized by substantial liver function impairment and the

onset of severe complications stemming from various causes such as chronic viral hepatitis,

alcohol-related liver disease, and genetic liver disorders.

Traditional management methods relying on periodic clinic visits and subjective assessments

often lead to delayed interventions and suboptimal patient care. Moreover, patients with DLD

encounter challenges in adhering to complex treatment regimens and lifestyle modifications,

further exacerbating their condition. To tackle these hurdles head-on, the IMHMS has been

meticulously developed.

The IMHMS harnesses the power of mobile application technology to enable real-time

data collection, analysis, and communication between patients and healthcare professionals.

This innovative approach facilitates comprehensive monitoring of disease progression, drug

adherence,rehabilitation, and overall quality of life, with the overarching goal of optimizing

patient outcomes and averting complications associated with DLD.

Key features of the IMHMS include:

1. Real-time Monitoring: Patients can seamlessly track their symptoms, medication

adherence, and relevant health metrics in real-time, allowing for early detection of changes in

their condition and prompt intervention when necessary.

2.Predictive Analysis Of DCLD Progression :

Prediction of future liver function based on patient - recorded DCLD alert symptoms

1. Sudden Increase in Abdominal Pain

2. Jaundice

3. Swelling or Fluid Retention

4. Confusion or Altered Mental Status

5. Vomiting Blood

6. Significant Weight Gain

7. Severe Fatigue

8. Difficulty Breathing

9. Persistent Fever

10. Signs of Hepatic Encephalopathy and improper drug compliance ,substance abuse and

investigations include blood tests to assess liver function, imaging studies such as ultrasound,

CT scan and UGI scopy , colonoscopy, and liver biopsy procedures for definitive diagnosis

and staging.Personalised risk assessment for complications like hepatic failure, hepatorenal

failure, hepato-pulmonary failure

2. Enhanced Patient Engagement: Through app-based monitoring, patients are empowered to

actively participate in their care, leading to improved adherence to treatment regimens and

lifestyle modifications.

3. Improved Communication: The IMHMS fosters enhanced communication and

collaboration between patients and healthcare providers, facilitating a more patient-centric

and collaborative approach to care delivery.

4. Personalized Care: Healthcare providers can access patient-generated data to tailor

treatment plans and interventions according to individual patient needs, ensuring a more

personalized and effective approach to care.

5. Efficient Data Collection and Analysis: Streamlined data collection and analysis processes

enable more informed decision-making and personalized care delivery, ultimately leading to

better patient outcomes.

6. Remote Monitoring: Remote monitoring capabilities reduce the need for frequent in-person

clinic visits, particularly benefiting patients facing geographical or logistical barriers to

accessing healthcare services.

By empowering patients to actively monitor and manage their DLD, the IMHMS holds the

potential to significantly improve overall quality of life, reduce symptom burden, and

enhance psychological well-being. In addition to monitoring disease progression and

medication adherence, the IMHMS also provides invaluable dietary advice and lifestyle

guidance crucial for effective DCLD management.

Patients are encouraged to follow a balanced diet, limit alcohol intake, maintain a healthy

weight,monitor sodium and protein intake, manage medications carefully, engage in regular

physical activity, and promptly seek medical advice in case of changes or worsening of

symptoms.Through these comprehensive measures, the IMHMS aims to revolutionize DCLD

management and pave the way for improved patient outcomes and enhanced quality of life.